Medicines for Europe President Marc-Alexander Mahl outlines the challenges facing the generic, biosimilar and value-added medicines industry and their role in achieving sustainable healthcare.
recently published
Horizon scanning
Jan 31 2024
Early Treatment: the role of biosimilars
18 2023 December
